Literature DB >> 11309373

Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene.

O Anusaksathien1, C Laplace, X Li, Y Ren, L Peng, S R Goldring, D L Galson.   

Abstract

The gene encoding the murine calcitonin receptor (mCTR) was isolated, and the exon/intron structure was determined. Analysis of transcripts revealed novel cDNA sequences, new alternative exon splicing in the 5'-untranslated region, and three putative promoters (P1, P2, and P3). The longest transcription unit is greater than 67 kilobase pairs, and the location of introns within the coding region of the mCTR gene (exons E3-E14) are identical to those of the porcine and human CTR genes. We have identified novel cDNA sequences that form three new exons as well as others that add 512 base pairs to the 5' side of the previously published cDNA, thereby extending exon E1 to 682 base pairs. Two of these novel exons are upstream of exon E2 and form a tripartite exon E2 (E2a, E2b, and E2c) in which E2a is utilized by promoter P2 with variable splicing of E2b. The third new exon (E3b') lies between E3a and E3b and is utilized by promoter P3. Analysis of mCTR mRNAs has revealed that the three alternative promoters give rise to at least seven mCTR isoforms in the 5' region of the gene and generate 5'-untranslated regions of very different lengths. Analysis by reverse transcription-polymerase chain reaction shows that promoters P1 and P2 are utilized in osteoclasts, brain, and kidney, whereas promoter P3 appears to be osteoclast-specific. Using transiently transfected reporter constructs, promoter P2 has activity in both a murine kidney cell line (MDCT209) and a chicken osteoclast-like cell line (HD-11EM), whereas promoter P3 is active only in the osteoclast-like cell line. These transfection data confirm the osteoclast specificity of promoter P3 and provide the first evidence that the CTR gene is regulated in a tissue-specific manner by alternative promoter utilization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309373     DOI: 10.1074/jbc.M007104200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells.

Authors:  Yan-Ping Zeng; Chao Yang; Yuan Li; Yong Fan; Hong-Jun Yang; Bin Liu; Hong-Xun Sang
Journal:  Mol Med Rep       Date:  2016-06-30       Impact factor: 2.952

2.  Evolutionary turnover of mammalian transcription start sites.

Authors:  Martin C Frith; Jasmina Ponjavic; David Fredman; Chikatoshi Kai; Jun Kawai; Piero Carninci; Yoshihide Hayashizaki; Yoshihide Hayshizaki; Albin Sandelin
Journal:  Genome Res       Date:  2006-05-10       Impact factor: 9.043

3.  Identification and characterization of anti-osteoclastogenic peptides derived from the cytoplasmic tail of receptor activator of nuclear factor kappa B.

Authors:  Yuu Taguchi; Yoko Kiga; Jin Gohda; Jun-Ichiro Inoue
Journal:  J Bone Miner Metab       Date:  2012-04-28       Impact factor: 2.626

4.  Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.

Authors:  Svetlana V Komarova; Alexey Pereverzev; Jonathan W Shum; Stephen M Sims; S Jeffrey Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-04       Impact factor: 11.205

5.  Calcr, a brain-specific imprinted mouse calcitonin receptor gene in the imprinted cluster of the proximal region of chromosome 6.

Authors:  Hidetoshi Hoshiya; Makiko Meguro; Akiko Kashiwagi; Chiga Okita; Mitsuo Oshimura
Journal:  J Hum Genet       Date:  2003-03-12       Impact factor: 3.172

6.  Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts.

Authors:  Yukiko Kuroda; Koichi Matsuo
Journal:  World J Orthop       Date:  2012-11-18

7.  Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.

Authors:  Jackie A Fretz; Nirupama K Shevde; Sujay Singh; Bryant G Darnay; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2007-12-06

8.  Large-scale, saturating insertional mutagenesis of the mouse genome.

Authors:  Alexander Gragerov; Kyoji Horie; Maria Pavlova; Linda Madisen; Hongkui Zeng; Galina Gragerova; Alex Rhode; Io Dolka; Patricia Roth; Amanda Ebbert; Stephanie Moe; Christopher Navas; Eric Finn; John Bergmann; Demetrios K Vassilatis; George N Pavlakis; George A Gaitanaris
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-24       Impact factor: 11.205

9.  NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

Authors:  Tania N Crotti; Merrilee Flannery; Nicole C Walsh; Joseph D Fleming; Steven R Goldring; Kevin P McHugh
Journal:  Gene       Date:  2006-03-02       Impact factor: 3.688

10.  Calcitonin induces expression of the inducible cAMP early repressor in osteoclasts.

Authors:  Maobin Yang; Barbara E Kream
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.